Wogonin is widely studied for its anti-inflammatory and neuroprotective properties, making it a compound of interest in the development of treatments for neurological disorders such as Alzheimer's and Parkinson's disease. It has shown potential in inhibiting key inflammatory pathways in the brain, which may help reduce neurodegeneration. In cancer research, wogonin exhibits antiproliferative effects against various tumor cell lines, including breast, liver, and leukemia cells. It induces apoptosis and cell cycle arrest, and may enhance the effectiveness of conventional chemotherapy drugs while reducing their side effects. It also demonstrates antiviral activity, particularly against influenza and certain DNA viruses, by interfering with viral replication processes. Additionally, wogonin has been explored for its antioxidant effects, helping to protect cells from oxidative stress-related damage. Due to its ability to modulate immune responses, it is being investigated for use in autoimmune conditions and allergic reactions. Its natural origin and low toxicity profile support its potential as a lead compound in developing safer therapeutic agents.